Double-edged Sword Role of Iron-loaded Ferritin in Extracellular Vesicles

被引:13
作者
Toyokuni, Shinya [1 ,2 ]
Kong, Yingyi [1 ]
Zheng, Hao [1 ]
Mi, Danyang [1 ]
Katabuchi, Misako [1 ]
Motooka, Yashiro [1 ]
Ito, Fumiya [1 ]
机构
[1] Nagoya Univ, Dept Pathol & Biol Responses, Grad Sch Med, Nagoya, Aichi, Japan
[2] Nagoya Univ, Ctr Lowtemp Plasma Sci, Nagoya, Aichi, Japan
关键词
Ferritin; Extracellular vesicles; Iron; Ferroptosis; Asbestos; ON FLUORESCENT-PROBE; CARCINOGENESIS; CHAPERONE; ASBESTOS; SULFIDE; MECHANISMS; OVERLOAD; CANCER;
D O I
10.15430/JCP.2021.26.4.244
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human epidemiological and animal studies have demonstrated that excess iron is a risk for cancer. The responsible mechanisms are: 1) increased intracellular iron catalyzes the Fenton reaction to generate hydroxyl radicals, leading to mutagenic oxidative DNA lesions; 2) iron is necessary for cellular proliferation as cofactors of many enzymes. Thus, iron-excess milieu promotes selecting cellular evolution to ferroptosis-resistance, a major basis for carcinogenesis. Ferritin is a 24-subunit nanocage protein required for iron storage under the regulation of the iron-regulatory protein (IRP)/iron-responsive element (IRE) system. Ferritin is a serum marker, representing total body iron storage. However, how ferritin is secreted extracellularly has been unelucidated. We recently discovered that an exosomal marker CD63 is regulated by the IRP/IRE system and that iron-loaded ferritin is secreted as extracellular vesicles under the guidance of nuclear receptor coactivator 4 (NCOA4). On the other hand, we found that macrophages under asbestos-induced ferroptosis emit ferroptosis-dependent extracellular vesicles (FedEVs), which are received by nearby mesothelial cells, resulting in significant mutagenic DNA damage. Therefore, cells, including macrophages, can share excess iron with other cells, via iron-loaded ferritin packaged in extracellular vesicles as safe non-catalytic iron. However, similar process, such as one involving FedEVs, may cause accumulation of excess iron in other specific cells, which may eventually promote carcinogenesis.
引用
收藏
页码:244 / 249
页数:6
相关论文
共 58 条
[41]   Iron addiction with ferroptosis-resistance in asbestos-induced mesothelial carcinogenesis: Toward the era of mesothelioma prevention [J].
Toyokuni, Shinya .
FREE RADICAL BIOLOGY AND MEDICINE, 2019, 133 :206-215
[42]   Iron and thiol redox signaling in cancer: An exquisite balance to escape ferroptosis [J].
Toyokuni, Shinya ;
Ito, Fumiya ;
Yamashita, Kyoko ;
Okazaki, Yasumasa ;
Akatsuka, Shinya .
FREE RADICAL BIOLOGY AND MEDICINE, 2017, 108 :610-626
[43]   The origin and future of oxidative stress pathology: From the recognition of carcinogenesis as an iron addiction with ferroptosis-resistance to non-thermal plasma therapy [J].
Toyokuni, Shinya .
PATHOLOGY INTERNATIONAL, 2016, 66 (05) :245-259
[44]   Mysterious link between iron overload and CDKN2A/2B [J].
Toyokuni, Shinya .
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2011, 48 (01) :46-49
[45]  
Toyokuni S, 2009, NAGOYA J MED SCI, V71, P1
[46]   Role of iron in carcinogenesis: Cancer as a ferrotoxic disease [J].
Toyokuni, Shinya .
CANCER SCIENCE, 2009, 100 (01) :9-16
[47]   Ferritin is secreted via 2 distinct nonclassical vesicular pathways [J].
Truman-Rosentsvit, Marianna ;
Berenbaum, Dina ;
Spektor, Lior ;
Cohen, Lyora A. ;
Belizowsky-Moshe, Shirly ;
Lifshitz, Lena ;
Ma, Jing ;
Li, Wei ;
Kesselman, Ellina ;
Abutbul-Ionita, Inbal ;
Danino, Dganit ;
Gutierrez, Lucia ;
Li, Huihui ;
Li, Kuanyu ;
Lou, Huifang ;
Regoni, Maria ;
Poli, Maura ;
Glaser, Fabian ;
Rouault, Tracey A. ;
Meyron-Holtz, Esther G. .
BLOOD, 2018, 131 (03) :342-352
[48]   PCBP2 Posttranscriptional Modifications Induce Breast Cancer Progression via Upregulation of UFD1 and NT5E [J].
Wang, Xiaonan ;
Guo, Qianying ;
Wang, Hao ;
Yuan, Xiaodong ;
Wang, Bijun ;
Lobie, Peter E. ;
Zhu, Tao ;
Tan, Sheng ;
Wu, Zhengsheng .
MOLECULAR CANCER RESEARCH, 2021, 19 (01) :86-98
[49]   Assessing iron status: Beyond serum ferritin and transferrin saturation [J].
Wish, Jay B. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 :S4-S8
[50]  
XIAO S, 1995, ONCOGENE, V11, P511